Korean J Pain.  2007 Dec;20(2):240-245. 10.3344/kjp.2007.20.2.240.

Intrathecal Catheter and Subcutaneous Access Port Implantation in Pain Management for Terminal Cancer Patient: A case report

• Seo KC
• Chung JY
• Kim HY
• Rho WS
• Kim BI
• Song SY

• KMID: 2278074
• DOI: http://doi.org/10.3344/kjp.2007.20.2.240

Abstract

It is important to treat cancer-related pain in cancer patients to ensure the life quality of the patient, as well as to improve their life span. It has been estimated that at least 5% of cancer patients have pain refractory to medical treatment. Therefore, the need for epidural or intrathecal analgesia with opioids and local anesthetics is indicated if systemic treatment has failed. Intrathecal catheter placement and implantation of the injection port for administration of opioids and local anesthetics may improve pain relief in patients who are unresponsive to epidural routes. Although intrathecal implantation has several complications, similar infection rates have been reported between intrathecal and epidural administration. In addition, intrathecal administration showed better outcomes, including improved pain control, lowered daily doses, and an improvement in the level of drowsiness experienced when compared to epidural administration. We report here a case in which a terminal cancer patient was treated using an intrathecal catheter and subcutaneous port. The patient had cancer-related pain that could not be controlled by epidural opioid administration. Based on the results presented here, we suggest that intrathecal implantation is a feasible long term pain management method for intractable cancer pain patients.

Keyword

intractable cancer pain; intrathecal; subcutaneous port implantation

MeSH Terms

Analgesia
Analgesics, Opioid
Anesthetics, Local
Catheters*
Humans
Pain Management*
Quality of Life
Sleep Stages
Analgesics, Opioid
Anesthetics, Local